| Medical News News, information and discussions about health issues, medicine and biotechnology. |
04-28-2009, 04:15 PM
|
#1
|
|
Senior Level 5
Join Date: Aug 2008
Location: Germany
Posts: 7,202
Thanks: 609
Thanked 346 Times in 257 Posts
|
How Morphine Can Be Given More Effectively Without Having To Increase Dosages
 |
One of the limitations in long-term use of morphine for pain relief is the rapid development of tolerance. The effectiveness of morphine declines quickly, and one must increase the dosage in order to preserve effective pain relief. However, the increased dosage also increases negative side effects.
The Hebrew University researchers, Prof. Yehuda Shavit and his graduate student Gilly Wolf of the Psychology Department, found that administration of morphine causes a substance called interleukin-1 to be released.
Under normal circumstances, interleukin-1 plays an important role in survival. In case of tissue damage, nerve injury, or inflammatory reaction, inteleukin-1 is released and sets off a process which increases the sensitivity to pain in the injured area. This pain serves as a warning signal, telling the body that there is a problem that should be attended to. In case of chronic pain, morphine is still the drug of choice for pain relief.
However, since prolonged administration of morphine raises the level of interleukin-1, thereby enhancing pain sensitivity, the effectiveness of morphine as a pain killer is steadily reduced, requiring greater dosages with accompanying negative side effects.
The Hebrew University researchers were able to show in animal experiments that administering morphine together with another drug that blocks the activity of interleukin-1 provides more effective pain relief over the long term without having to increase the dosage.
Shavit, who is the Leon and Clara Sznajderman Professor of Psychology at the Hebrew University and whose specialty is psychoneuroimmunology, expressed hope that this research will make it possible for clinicians to make use of morphine, together with substances that block interluekin-1, in order to bring about better pain relief with lower dosages and with minimized side effects. The research will be presented at a conference on pain research on May 3 on the Mount Scopus campus of the university. The conference is open to journalists and to people in the field.
|
Full article here:
http://www.sciencedaily.com/releases...0427075422.htm
__________________
There are always dozens of reasons why something "can't" be done. That's no excuse in my book. If you want it bad enough, you find a way. That's how life works for grown ups. -- Booger
Do not keep calm and carry on.
Put on your big girl panties & sexiest boots
and kick some ass.
|
|
|
| Thread Tools |
Search this Thread |
|
|
|
| Display Modes |
Threaded Mode
|
Posting Rules
|
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts
HTML code is Off
|
|
|
All times are GMT -4. The time now is 03:29 PM.
|